USA Shipped · Chino, California
CoreVials.com Research Peptides
Shop Autoship GLP Plans Blog Contact
Sign In
Research Use Only Products are for laboratory research only, not for human or animal consumption. Research Compliance
Research Reference

Survodutide Research Reference

Complete research reference and reconstitution guide for Survodutide.

Research Use Only Reconstitution Math Storage Reference

Quick Reference

Vial Amount
10mg
CoreVials Standard Mix
Add 1mL BAC Water
Final Concentration
10mg/mL
Easy Reference
10 units = 1mg
Storage
Refrigerate after reconstitution

This page is for research-use-only educational reference and measurement math. It is not medical, veterinary, dosing, administration, or treatment guidance. Products are not for human or animal consumption.

On this page

How This Works

Survodutide is a dual agonist that activates both GLP‑1 and glucagon receptors[1]. The GLP‑1 component enhances satiety and improves glycemic control, while the glucagon component increases energy expenditure and promotes hepatic lipid oxidation[3]. This dual mechanism is hypothesized to provide additive or synergistic effects on body weight and liver fat beyond GLP‑1 agonism alone[4]. In phase 2 trials, survodutide demonstrated substantial weight loss alongside improvements in liver enzyme markers[1][2].

CoreVials Standard Mix

For a 10mg vial Add 1mL BAC Water
Final concentration 10mg/mL

After mixing (U-100 syringe reference)

  • 5 units=0.5mg
  • 10 units=1mg
  • 20 units=2mg

These are example measurement calculations only. They are not dosing, administration, medical, or veterinary guidance.

Other Mix Options
BAC Added Final Concentration 0.5mg Equals 1mg Equals
1mL CoreVials Standard Mix 10mg/mL 5 units 10 units
2mL 5mg/mL 10 units 20 units
3mL 3.33mg/mL 15 units 30 units

Supply Planning

Products commonly paired for research preparation:

  • Survodutide Research Reference
  • BAC Water
  • Cryo labels
  • Storage case
Shop Peptides View BAC Water

References

Lancet Diabetes & Endocrinology (2024)
— Le Roux et al. Phase 2 trial of once‑weekly SC survodutide (0.6–4.8 mg) in obesity; dose‑dependent weight loss of 12.5–14.9%

Journal of Hepatology (2023)
— Guo et al. Efficacy, tolerability, and pharmacokinetics of survodutide in NAFLD/NASH research samples (cirrhosis cohort)

Obesity (Silver Spring) (2024)
— Wharton et al. SYNCHRONIZE‑1 & 2 phase 3 trial design for survodutide in obesity

JACC: Heart Failure (2024)
— Kosiborod et al. SYNCHRONIZE‑CVOT design: survodutide in research samples at cardiovascular risk

Diabetology & Metabolic Syndrome (2024)
— Wan et al. Meta‑analysis of survodutide weight‑loss efficacy across randomized controlled trials

Nature Reviews Endocrinology (2023)
— GLP‑1/glucagon dual agonism: mechanistic overview and research potential

View Source

CDC
— Vaccine preparation: route (angle/site guidance; no aspiration required)

CDC (Subcut Measurement PDF)
— Technique diagram and site guidance for measurements

MedlinePlus (NIH)
— Giving an insulin measurement: research sample guide for technique

Veterans Affairs (2023)
— Insulin measurement: how to use and where to measure (measurement sites, rotation guidance)

NCBI Bookshelf
— Best practices for measurement (asepsis, preparation, and preparation)

Drug Measurement Review (PMC)
— Pharmacologic considerations of the route

Research Use Notice

This page is research-use-only educational reference and measurement math. It is not medical, veterinary, dosing, administration, or treatment guidance. Products are not for human or animal consumption.

Need research supplies?

High-purity peptides and lab essentials with batch-level COA transparency.

Shop Peptides View BAC Water

Related Protocols

Research Use Only Products are for laboratory research only, not for human or animal consumption. Research Compliance